Hyperpolarized Carbon-13 Alpha-ketoglutarate imaging

carbon-13 alpha-ketoglutarate imaging agent

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hyperpolarized Carbon-13 Alpha-ketoglutarate imaging, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma [EARLY_Phase 1]

See pricing